BRAIDWELL LP

Position in DYN — Dyne Therapeutics, Inc.

CIK 1920938 STAMFORD, CT

Position in DYN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$30,494,623

+$1,578,508 QoQ

Shares Held

1,681,998

+13.8% QoQ

Ownership

1.18%

of shares outstanding

% of Portfolio

1.16%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BRAIDWELL LP holds $1,648,117,197 across 48 Biotechnology names. DYN ranks #20 (1.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CAI	Caris Life Sciences, Inc.	8,009,447	$143,208,912
2	CNTA	Centessa Pharmaceuticals plc	1,986,768	$78,914,424
3	XENE	Xenon Pharmaceuticals Inc.	1,338,452	$77,830,983
4	DNTH	Dianthus Therapeutics, Inc. /DE/	899,364	$75,474,626
5	EWTX	Edgewise Therapeutics, Inc.	2,347,583	$73,948,864
6	NUVL	Nuvalent, Inc.	700,429	$71,758,951
7	KOD	Kodiak Sciences Inc.	1,818,665	$69,327,509
8	CGON	CG Oncology, Inc.	984,783	$66,650,113

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$30,494,623	1,681,998	+13.8%	Shares	Sole	2026-05-15
2025-12-31	$28,916,115	1,478,329	-45.9%	Shares	Sole	2026-02-17
2025-09-30	$34,540,584	2,730,481	-16.6%	Shares	Sole	2025-11-14
2025-06-30	$31,162,282	3,273,349	-9.6%	Shares	Sole	2025-08-14
2025-03-31	$37,879,258	3,621,344	+431.6%	Shares	Sole	2025-05-15
2024-12-31	$16,048,647	681,182	-9.9%	Shares	Sole	2025-02-14
2023-12-31	$10,052,286	755,811	-58.5%	Shares	Sole	2024-02-14
2023-09-30	$16,324,869	1,821,972	+32.2%	Shares	Sole	2023-11-14
2023-06-30	$15,501,060	1,377,872	0.0%	Shares	Sole	2023-08-14
2023-03-31	$15,873,085	1,377,872	+82.9%	Shares	Sole	2023-05-15
2022-12-31	$8,728,950	753,145	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.